Bush Rx discount card
House Small Business Committee is understood to have tentatively scheduled a hearing for mid-September on the effect President Bush's prescription drug discount card plan would have on pharmacies. During a July 25 Small Business Committee hearing on reducing regulatory burdens on small healthcare providers, Ranking Democrat Velazquez (N.Y.) asked Centers for Medicare & Medicaid Services Administrator Tom Scully to provide a report on the discount card's impact. National Community Pharmacists Association and the National Association of Chain Drug Stores filed for a preliminary court injunction against the program July 26 (1"The Pink Sheet" July 23, p. 5)
You may also be interested in...
The Bush Administration's Medicare prescription discount card plan would not require participating prescription benefit programs to report rebates to the government or pass on savings to beneficiaries.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials